ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/02/2026
Back to search
Official data from USPTO
NIGHT FEVER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
07/02/2026
Trademark type
Word
Nice classes
5
Filing date
11/30/2021
Registration date
11/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2024
Last transaction
07/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
FR
Examiner
ANGOTTI, SALVATORE JOHN
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BIOFAR
Representatives
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsdietetic foods adapted for medical usedietetic substances adapted for paramedical use which may contain proteinscarbohydrateslipids and fibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; pharmaceutical preparationsparapharmaceutical products and food supplements for medical and paramedical usepharmaceutical preparationsparapharmaceutical products and food supplements for medical and paramedical use which may contain proteinscarbohydrateslipids and fibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; pharmaceutical preparations and parapharmaceutical products made from plantsextracts of plants and vegetable extracts in effervescent and other forms for enhancing energy production in the body; pharmaceutical preparations and parapharmaceutical products containing minerals and vitamins in effervescent and other forms; vitamins and minerals in effervescent and other formsgranules; pharmaceutical preparations and parapharmaceutical products for phytotherapy; food supplements for medical use as additions to the nutrient intake in a normal diet; nutritional supplements for paramedical use for enhancing energy production in the body as additions to the nutrient intake in a normal dietwhich may contain proteinscarbohydrateslipids and fibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; all dietetic substances adapted for medical and paramedical use which may contain proteinscarbohydrateslipids and fibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; food supplements for medical use prepared for human consumption from food ingredients of vegetable and mineral origin; nutritional supplements for paramedical use prepared for human consumption from food ingredients of vegetable and mineral originwhich may contain proteinscarbohydrateslipidsfibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; fortifying foodstuffs for medical use; fortifying foodstuffs for paramedical use which may contain proteinscarbohydrateslipids and fibresmicronutrients such as vitamins and mineralsamino acids and fatty acidsin individual doses such as capsuleseffervescent tabletsnon-effervescent tabletspillsgelatin capsulessachetschewing gumsdry extracts and powders for pharmaceutical and parapharmaceutical usegranular powderscellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body
Publications
History of USPTO decisions and trademark events.
44 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/18/2025
FIMP
FINAL DISPOSITION PROCESSED
04/18/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/26/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/26/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2024
PUBO
PUBLISHED FOR OPPOSITION
09/24/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/21/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/08/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/10/2024
GNRT
NON-FINAL ACTION E-MAILED
01/10/2024
CNRT
NON-FINAL ACTION WRITTEN
01/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/22/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/22/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2023
GNRT
NON-FINAL ACTION E-MAILED
07/10/2023
CNRT
NON-FINAL ACTION WRITTEN
07/10/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/24/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/24/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/22/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/22/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/09/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/09/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/09/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/09/2023
RFNT
REFUSAL PROCESSED BY IB
12/11/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/21/2022
RFRR
REFUSAL PROCESSED BY MPU
11/21/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/20/2022
CNRT
NON-FINAL ACTION WRITTEN
09/19/2022
DOCK
ASSIGNED TO EXAMINER
09/09/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
12/27/2021
Continuous trademark protection
Get notified about every new filing that threatens NIGHT FEVER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.